Current and Future Clinical Applications American Heart Association Monograph Series Edited by Jesse E. Adams III, MD, FACC , Investigator, Jewish Hospital Heart and Lung Institute, Assistant Clinical Professor of Medicine, Division of Cardiology, University of Louisville, Louisville, KY Fred S. Apple, PhD , Medical Director, Clinical Laboratories, Hennepin County Medical Center, Professor of Laboratory Medicine and Pathology, University of Minnesota School of Medicine, Minneapolis, MN Allan S. Jaffe, MD , Senior Assistant Consultant, Mayo Clinic, Professor of Medicine, Cardiovascular Division, Mayo Medical School, Rochester, MN Alan H.B. Wu, PhD , Professor, Department of Pathology and Laboratory Medicine, Hartford Hospital, Hartford, CT 288 pp. The sooner this can be confirmed, the sooner proper treatment can be instituted. This is not only true for ischemic heart disease, but also in drug-induced myocardial damage.
Many tables supplement the text.
The index is helpful and each of the chapters is accompanied by many recent references, up to 132. This book is recommended for all clinicians who deal with patients with ischemic heart disease. Diagnostic accuracy is critical for the identification and treatment of patients with potential cardiac disease. The chapters in this monograph detail the past, present, and potential future of markers used for the detection of myocardial injury and for risk assessment as part of a cardiovascular disease work-up strategy. Clinical cardiologists, pathologists, researchers, and critical and primary care physicians interested in the clinical application of blood-based assays in cardiac patients will all learn from this monograph.